Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study.
Johnson ES, Thorp ML, Platt RW, Smith DH. Johnson ES, et al. Among authors: thorp ml. Am J Kidney Dis. 2008 Oct;52(4):653-60. doi: 10.1053/j.ajkd.2008.04.026. Epub 2008 Jun 30. Am J Kidney Dis. 2008. PMID: 18585833
Use of recombinant erythropoietin in a pregnant renal transplant recipient.
Thorp M, Pulliam J. Thorp M, et al. Am J Nephrol. 1998;18(5):448-51. doi: 10.1159/000013369. Am J Nephrol. 1998. PMID: 9730574
A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients.
Thorp ML, Morris CD, Bagby SP. Thorp ML, et al. Am J Kidney Dis. 2001 Jul;38(1):104-8. doi: 10.1053/ajkd.2001.25202. Am J Kidney Dis. 2001. PMID: 11431189 Clinical Trial.
Three diabetic peritoneal dialysis patients receiving intraperitoneal insulin with dosage adjustment based on capillary glucose levels during peritoneal equilibrium tests.
Thorp ML, Wilks TS. Thorp ML, et al. Am J Kidney Dis. 2004 May;43(5):927-9. doi: 10.1053/j.ajkd.2003.12.055. Am J Kidney Dis. 2004. PMID: 15112185
Potential application of the National Kidney Foundation's chronic kidney disease guidelines in a managed care setting.
Thorp ML, Eastman L. Thorp ML, et al. Am J Manag Care. 2004 Jul;10(7 Pt 1):417-22. Am J Manag Care. 2004. PMID: 15298363
A study of the prevalence of significant increases in serum creatinine following angiotension-converting enzyme inhibitor administration.
Thorp ML, Ditmer DG, Nash MK, Wise R, Jaderholm PL, Smith JD, Chan W. Thorp ML, et al. J Hum Hypertens. 2005 May;19(5):389-92. doi: 10.1038/sj.jhh.1001832. J Hum Hypertens. 2005. PMID: 15703773
Managing the burden of chronic kidney disease.
Thorp ML, Eastman L, Smith DH, Johnson ES. Thorp ML, et al. Dis Manag. 2006 Apr;9(2):115-21. doi: 10.1089/dis.2006.9.115. Dis Manag. 2006. PMID: 16620197 Review.
Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease.
DeVille J, Thorp ML, Tobin L, Gray E, Johnson ES, Smith DH. DeVille J, et al. Among authors: thorp ml. Nephrology (Carlton). 2006 Dec;11(6):555-9. doi: 10.1111/j.1440-1797.2006.00698.x. Nephrology (Carlton). 2006. PMID: 17199797 Clinical Trial.
Predicting renal replacement therapy and mortality in CKD.
Johnson ES, Thorp ML, Yang X, Charansonney OL, Smith DH. Johnson ES, et al. Among authors: thorp ml. Am J Kidney Dis. 2007 Oct;50(4):559-65. doi: 10.1053/j.ajkd.2007.07.006. Am J Kidney Dis. 2007. PMID: 17900455
Secular trends in kidney disease: is the decreased incidence of renal replacement therapy due to a decrease in chronic kidney disease incidence?
Thorp ML, Weinstein JR, Johnson ES, Yang X, Smith DH. Thorp ML, et al. Clin Nephrol. 2008 Sep;70(3):187-93. doi: 10.5414/cnp70187. Clin Nephrol. 2008. PMID: 18793559
62 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback